Systematic review: immediate drugs for severe asymptomatic hypertension show no consistent 7-day benefit
A systematic review of seven studies found no consistent 7-day clinical benefit from immediate drug treatment of severe hypertension without organ damage in acute care.

A systematic review in BMC Emergency Medicine compared immediate drug-based blood pressure lowering with conservative or observational management in adults with severe hypertension and no acute target-organ damage. The authors, Tangpaisarn, Wongtanasarasin, Na Thalang and Kotruchin, searched PubMed, Embase, Web of Science and Scopus from inception to January 2026. Seven studies met the inclusion criteria: one randomized controlled trial and six observational studies biomedcentral.com
BMC Emergency Medicinebiomedcentral.comOpen source ↗.
Severe asymptomatic hypertension is common in acute care. Markedly elevated pressure often prompts immediate drug treatment, although comparative evidence that this improves short-term outcomes is limited, according to the authors. The review included comparative studies in emergency departments (ED) and inpatient acute care. The primary outcome was adverse clinical events within 7 days.
Emergency department findings
Because of substantial clinical and methodological heterogeneity, the authors synthesized the results narratively and assessed ED and inpatient evidence separately. Among ED populations, major adverse cardiovascular events were uncommon. Immediate drug treatment was not associated with a consistent reduction in adverse events or in healthcare utilization within 7 days.
The single randomized trial found similar short-term reductions in blood pressure with oral antihypertensive therapy and with rest alone biomedcentral.com
BMC Emergency Medicinebiomedcentral.comOpen source ↗.
Inpatient observational signals
The second group consisted of hospitalized patients who developed severe hypertension during admission for unrelated conditions. In observational studies, intravenous antihypertensive therapy was associated with a greater likelihood of excessive blood pressure reduction and of myocardial injury.
The authors stress the limits of these data. The inpatient findings came from overlapping cohorts and remain susceptible to residual confounding by indication. The associations should not be interpreted as causal or directly extrapolated to ED populations.
The authors concluded that the available evidence does not demonstrate a consistent short-term clinical benefit of immediate drug-based blood pressure lowering in adults with severe hypertension without acute target-organ damage. They state that further well-designed prospective studies are needed biomedcentral.com
BMC Emergency Medicinebiomedcentral.comOpen source ↗.



